P
Psycheceutical
Psycheceutical is removing barriers to care by employing groundbreaking patented delivery technologies to provide safe and effective psychedelic pharmaceutical medicines
About Psycheceutical
Psycheceutical, Inc. is a biotechnology company focused on developing innovative delivery technologies for psychedelic pharmaceuticals aimed at mental health treatment. The company leverages its patented delivery systems to enhance the safety and efficacy of psychedelic compounds, addressing a critical need in the healthcare industry for more controlled and effective treatments. Psycheceutical operates in the mental health market, targeting healthcare providers and patients seeking advanced therapeutic options for conditions such as depression, PTSD, and anxiety. The business model revolves around the research, development, and commercialization of these proprietary delivery technologies, generating revenue through licensing agreements, partnerships, and direct sales of their pharmaceutical products. With a team boasting over 100 years of combined experience in psychedelics, biotechnology, and pharmaceutical business development, Psycheceutical is well-positioned to lead the next generation of mental health treatments.
Source: Dealroom company dataAt a glance
- Founded
- 2020
- Headquarters
- Fort Lauderdale, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Psycheceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Psycheceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.